Imaging Plaques to Predict and Better Manage Patients With Acute Coronary Events
暂无分享,去创建一个
Jason C. Kovacic | Zahi A. Fayad | Hector M. Garcia-Garcia | Patrick W. Serruys | P. Serruys | Z. Fayad | H. Garcia-Garcia | J. Narula | J. Kovacic | I. Jang | Ik-Kyung Jang | Jagat Narula
[1] Hiroshi Takahashi,et al. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention. , 2010, Clinical therapeutics.
[2] Samin K. Sharma,et al. Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy). , 2013, Journal of the American College of Cardiology.
[3] Jean-Claude Tardif,et al. In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study. , 2009, JACC. Cardiovascular imaging.
[4] S. Nissen. Halting the progression of atherosclerosis with intensive lipid lowering: results from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. , 2005, The American journal of medicine.
[5] R. Virmani,et al. Culprit plaque in myocardial infarction going beyond angiography. , 2007, Journal of the American College of Cardiology.
[6] James E. Muller,et al. Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. , 2008, JACC. Cardiovascular imaging.
[7] Peter Libby,et al. Effect of two intensive statin regimens on progression of coronary disease. , 2011, The New England journal of medicine.
[8] Jean-Claude Tardif,et al. Effect of torcetrapib on the progression of coronary atherosclerosis. , 2007, The New England journal of medicine.
[9] J. Deckers,et al. Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study). , 2007, The American journal of cardiology.
[10] René M. Botnar,et al. Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction. , 2009, JACC. Cardiovascular imaging.
[11] K. Node,et al. High-intensity signals in coronary plaques on noncontrast T1-weighted magnetic resonance imaging as a novel determinant of coronary events. , 2014, Journal of the American College of Cardiology.
[12] Akiko Maehara,et al. Clinical and angiographic characteristics of patients likely to have vulnerable plaques: analysis from the PROSPECT study. , 2013, JACC. Cardiovascular imaging.
[13] Zahi A. Fayad,et al. Imaging of atherosclerotic cardiovascular disease , 2008, Nature.
[14] C. Yuan,et al. Accuracy of MRI to identify the coronary artery plaque: A comparative study with intravascular ultrasound , 2012, Journal of magnetic resonance imaging : JMRI.
[15] A. Yeung,et al. Impact of coronary artery remodeling on clinical presentation of coronary artery disease: an intravascular ultrasound study. , 2001, Journal of the American College of Cardiology.
[16] Frits Mastik,et al. Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque , 2008, Circulation.
[17] Raimund Erbel,et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. , 2006, JAMA.
[18] E. Tuzcu,et al. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. , 2008, JAMA.
[19] Colin Berry,et al. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. , 2007, JAMA.
[20] J. Lindsay,et al. Predictors of coronary arterial remodeling patterns in patients with myocardial ischemia. , 1997, The American journal of cardiology.
[21] Antonio Colombo,et al. Intravascular Ultrasound Assessment of Ulcerated Ruptured Plaques: A Comparison of Culprit and Nonculprit Lesions of Patients With Acute Coronary Syndromes and Lesions in Patients Without Acute Coronary Syndromes , 2003, Circulation.
[22] C. Zarins,et al. Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.
[23] Carl J Pepine,et al. Effect of ACAT inhibition on the progression of coronary atherosclerosis. , 2006, The New England journal of medicine.
[24] Byeong Ha Lee,et al. Combined system of optical coherence tomography and fluorescence spectroscopy based on double-cladding fiber. , 2008, Optics letters.
[25] Yen-Hung Lin,et al. The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[26] Y. Neishi,et al. Measurement of the thickness of the fibrous cap by optical coherence tomography. , 2006, American heart journal.
[27] M. Caulfield,et al. Effects of torcetrapib in patients at high risk for coronary events. , 2007, The New England journal of medicine.
[28] Diane M. Miller,et al. Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in Diabetes Patients With Cardiovascular History Trial , 2010, Circulation.
[29] Z. Fayad,et al. Effect of treatment for 12 weeks with rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-positron emission tomography imaging. , 2014, Journal of the American College of Cardiology.
[30] Paul Schoenhagen,et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. , 2003, JAMA.
[31] C. Cogbill,et al. Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform? , 2003, Journal of the American College of Cardiology.
[32] Jagat Narula,et al. The popcorn plaques , 2007, Nature Medicine.
[33] Pai-Chi Li,et al. Integrated intravascular ultrasound and photoacoustic imaging scan head. , 2010, Optics letters.
[34] M. Szklo,et al. MRI detects increased coronary wall thickness in asymptomatic individuals: The multi‐ethnic study of atherosclerosis (MESA) , 2008, Journal of magnetic resonance imaging : JMRI.
[35] Pankaj Garg,et al. Arithmetic of vulnerable plaques for noninvasive imaging , 2008, Nature Clinical Practice Cardiovascular Medicine.
[36] P. Serruys,et al. Coronary plaque composition of nonculprit lesions, assessed by in vivo intracoronary ultrasound radio frequency data analysis, is related to clinical presentation. , 2006, American heart journal.
[37] Eric J Topol,et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. , 2004, JAMA.
[38] P. Pais,et al. Darapladib for preventing ischemic events in stable coronary heart disease. , 2014, The New England journal of medicine.
[39] A. Jeremias,et al. Coronary artery compliance and adaptive vessel remodelling in patients with stable and unstable coronary artery disease , 2000, Heart.
[40] R. Virmani,et al. Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. , 2007, Journal of the American College of Cardiology.
[41] H. Sillesen,et al. Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET). , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[42] T. Akasaka,et al. Feasibility of noninvasive assessment of thin-cap fibroatheroma by multidetector computed tomography. , 2009, JACC. Cardiovascular imaging.
[43] Patrick W Serruys,et al. Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[44] Hirofumi Anno,et al. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. , 2007, Journal of the American College of Cardiology.
[45] Ahmed Tawakol,et al. Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. , 2010, JACC. Cardiovascular imaging.
[46] D. Glogar,et al. Intravascular ultrasound predictors of major adverse cardiac events in patients with unstable angina , 2000, Clinical cardiology.
[47] Evelyn Regar,et al. In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study. , 2014, European heart journal.
[48] Stanislav Y. Emelianov,et al. Development of a catheter for combined intravascular ultrasound and photoacoustic imaging. , 2010, The Review of scientific instruments.
[49] Ahmed Tawakol,et al. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial , 2011, The Lancet.
[50] Bo Yu,et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. , 2013, Journal of the American College of Cardiology.
[51] C von Birgelen,et al. Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo. , 2001, Journal of the American College of Cardiology.
[52] B. Bouma,et al. Association of statin therapy with reduced coronary plaque rupture: an optical coherence tomography study , 2008, Coronary artery disease.
[53] S. Achenbach,et al. Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography. , 2006, Journal of the American College of Cardiology.
[54] Takashi Akasaka,et al. The effect of lipid and inflammatory profiles on the morphological changes of lipid-rich plaques in patients with non-ST-segment elevated acute coronary syndrome: follow-up study by optical coherence tomography and intravascular ultrasound. , 2010, JACC. Cardiovascular interventions.
[55] J. Kastelein,et al. Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. , 2014, JAMA.
[56] Zahi A. Fayad,et al. Perspectives and opportunities for nanomedicine in the management of atherosclerosis , 2011, Nature Reviews Drug Discovery.
[57] H. Fujita,et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. , 2005, Journal of the American College of Cardiology.
[58] Akiko Maehara,et al. A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.
[59] V. Fuster,et al. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. , 2013, Journal of the American College of Cardiology.
[60] Renu Virmani,et al. Vulnerable plaque: the pathology of unstable coronary lesions. , 2002, Journal of interventional cardiology.
[61] D. Vince,et al. Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[62] M Valgimigli,et al. Coronary artery remodelling is related to plaque composition , 2005, Heart.
[63] P. Libby. Inflammation in atherosclerosis , 2002, Nature.
[64] Brett E Bouma,et al. Measurement of collagen and smooth muscle cell content in atherosclerotic plaques using polarization-sensitive optical coherence tomography. , 2007, Journal of the American College of Cardiology.
[65] C. Rochitte,et al. Regression of coronary artery outward remodeling in patients with non-ST-segment acute coronary syndromes: a longitudinal study using noninvasive magnetic resonance imaging. , 2006, American heart journal.
[66] R. Virmani,et al. Coronary CT angiographic characteristics of culprit lesions in acute coronary syndromes not related to plaque rupture as defined by optical coherence tomography and angioscopy. , 2011, European heart journal.
[67] R. Virmani,et al. Concept of vulnerable/unstable plaque. , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[68] A. Yeung,et al. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. , 1995, The New England journal of medicine.
[69] René M. Botnar,et al. Visualization of Coronary Wall Atherosclerosis in Asymptomatic Subjects and Patients with Coronary Artery Disease Using Magnetic Resonance Imaging , 2010, PloS one.
[70] Akiko Maehara,et al. Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. , 2002, Journal of the American College of Cardiology.
[71] V. Fuster,et al. OCT-based diagnosis and management of STEMI associated with intact fibrous cap. , 2013, JACC. Cardiovascular imaging.
[72] M. Dweck,et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial , 2014, The Lancet.
[73] G. Pasterkamp,et al. Multiple complex coronary plaques in patients with acute myocardial infarction. , 2001, The New England journal of medicine.
[74] Masatoshi Ishibashi,et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. , 2006, Journal of the American College of Cardiology.
[75] V. Fuster,et al. 2-deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis , 2014, Nature Medicine.
[76] Michail I. Papafaklis,et al. Prediction of Progression of Coronary Artery Disease and Clinical Outcomes Using Vascular Profiling of Endothelial Shear Stress and Arterial Plaque Characteristics: The PREDICTION Study , 2012, Circulation.
[77] Yoram Rudy,et al. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. , 2006, The American journal of cardiology.
[78] Takashi Akasaka,et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. , 2007, Journal of the American College of Cardiology.
[79] M. McConnell,et al. Noninvasive assessment of coronary vasodilation using cardiovascular magnetic resonance in patients at high risk for coronary artery disease , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[80] D. Berman,et al. Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia. , 2014, JACC. Cardiovascular interventions.
[81] Takashi Akasaka,et al. Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study. , 2009, Atherosclerosis.
[82] Gary S Mintz,et al. Intravascular Ultrasound Analysis of Infarct‐Related and Non‐Infarct‐Related Arteries in Patients Who Presented With an Acute Myocardial Infarction , 2003, Circulation.
[83] J. H. Rudd,et al. Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis. , 2012, JACC. Cardiovascular imaging.
[84] P. Joshi,et al. Coronary atherosclerosis imaging by coronary CT angiography: current status, correlation with intravascular interrogation and meta-analysis. , 2011, JACC. Cardiovascular imaging.
[85] M. Bennett,et al. Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study. , 2011, JACC. Cardiovascular imaging.
[86] René M. Botnar,et al. Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI. , 2006, European heart journal.
[87] R. Virmani,et al. Clinical Feasibility of Molecular Imaging of Plaque Inflammation in Atherosclerosis , 2009, Journal of Nuclear Medicine.